Qiagen Real Time Semi-Quantitative PCR (RT-qPCR) and Digital PCR (dPCR) System or Equal
ID: 75N9524Q00575Type: Combined Synopsis/Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH NIDABethesda, MD, 20892, USA

NAICS

Analytical Laboratory Instrument Manufacturing (334516)

PSC

LABORATORY EQUIPMENT AND SUPPLIES (6640)

Set Aside

Total Small Business Set-Aside (FAR 19.5) (SBA)

Original Source

https://sam.gov/opp/e88c98e99ce0479cadafb0518696df41/view
Timeline
    Description

    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for a Qiagen Real Time Semi-Quantitative PCR (RT-qPCR) and Digital PCR (dPCR) System or an equivalent product. The procurement aims to support research into neurodegenerative diseases and retroviral infections, requiring a system with multiplex capability for detecting five gene targets, automated operation, low variability in results, and a compact size not exceeding 16” x 28” x 20”. Proposals must be submitted by 9:00 a.m. Eastern Time on September 17, 2024, and should include a completed copy of certain FAR clauses and the Unique Entity ID. For further inquiries, interested parties can contact Frederick Weddington at frederick.weddington@nih.gov or by phone at 301-594-6835.

    Point(s) of Contact
    Frederick Weddington
    (301) 594-6835
    frederick.weddington@nih.gov
    Files
    Title
    Posted
    Comb_Synop-Solicit-COMPETITIVE - PCR - (Final).pdf
    The government document outlines a Request for Quotations (RFQ) for a Real Time semi-quantitative PCR (RT-qPCR) and digital PCR (dPCR) system from Qiagen LLC or an equivalent product. It is issued by the National Institute of Neurological Disorders and Stroke (NINDS) within the National Institutes of Health (NIH), aimed at supporting research into neurodegenerative diseases and retroviral infections. The acquisition falls under Federal Acquisition Regulation (FAR) Simplified Acquisition Procedures, with a small business set-aside for Service Disabled Veteran Owned Small Businesses. Key requirements for the PCR system include multiplex capability for detecting five gene targets, automated operation without transferring samples between machines, low variability in results, and a total bench space of no more than 16” x 28” x 20”. Successful delivery and installation within 42–56 days post-order are mandated, alongside on-site training by a certified technician. Proposals are due by 9:00 a.m. Eastern Time on September 17, 2024, and must include a completed copy of certain FAR clauses and the Unique Entity ID. The evaluation criteria for bids will focus on technical capability, price, and past performance, emphasizing the importance of the equipment to ongoing biomedical research.
    Lifecycle
    Title
    Type
    Qiagen Real Time Semi-Quantitative PCR (RT-qPCR) and Digital PCR (dPCR) System or Equal
    Currently viewing
    Combined Synopsis/Solicitation
    Similar Opportunities
    Qiagen LLC QIAsymphony DSP DNA Midi Kits, filter tips and supplies
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) intends to issue a sole source firm fixed-price purchase order to Qiagen LLC for QIAsymphony DSP DNA Midi Kits, filter tips, and related supplies, essential for the Microbiology Service section of the Department of Laboratory Medicine. This procurement aims to acquire reagents and supplies necessary for the efficient extraction of nucleic acids from clinical samples, which is critical for timely detection of infectious agents and supporting ongoing clinical testing. The items will be utilized with existing QIAsymphony SP and QIAgility instruments, which are vital for the laboratory's operations and the development of novel tests. Interested parties may submit their capability statements to Shasheshe Goolsby at shasheshe.goolsby@nih.gov by November 14, 2024, at 2:30 PM EST, as this is not a request for proposals.
    Revio reagent kit, 24pack All reagents for sequenc
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to procure the Revio reagent kit, which includes a 24-pack of all reagents necessary for sequencing 24 Revio SMRT Cells. This solicitation aims to acquire essential laboratory supplies that are critical for advanced genomic sequencing applications. The Revio reagent kit plays a vital role in supporting research and development in the field of genomics and personalized medicine. Interested vendors can reach out to Dorothy L. Maxwell at dorothy.maxwell@nih.gov or call 301-827-7729 for further details regarding the procurement process.
    BD Biosciences Proprietary Instrumentation Package and Reagent Kits
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to procure a proprietary instrumentation package and reagent kits from Becton, Dickinson & Company for the Department of Laboratory Medicine. This acquisition aims to secure essential supplies, including instrument rentals and quality control materials, necessary for the operation of the Hematology Flow Cytometry Service, which plays a critical role in patient care and research. The procurement is vital for maintaining the laboratory's capacity to deliver timely and accurate results, as the specified reagent kits are uniquely compatible with the existing BD Rhapsody™ single cell analysis system. Interested parties may submit capability statements to Shasheshe Goolsby at shasheshe.goolsby@nih.gov by November 14, 2024, at 6:30 AM EST, as this is a presolicitation notice and not a request for quotations.
    SOURCES SOUGHT: Long read sequencing services
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified small businesses to provide long read sequencing services as part of the Global Parkinson’s Genetics Program (GP2). The objective is to genotype over 150,000 individuals worldwide to enhance understanding of genetic risk factors associated with Parkinson’s Disease, requiring the contractor to perform long read sequencing on 500 human genomic DNA samples with a minimum coverage of 25X per sample, alongside ancillary services such as DNA fragmentation, library preparation, and bioinformatics support. Interested parties must submit their capability statements by November 15, 2024, at 9:00 AM Eastern Time, to Rashiid Cummins at rashiid.cummins@nih.gov, ensuring compliance with the specified guidelines and format.
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits
    Active
    Health And Human Services, Department Of
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits The Department of Health and Human Services, Department of, National Institutes of Health, is planning to procure BD Rhapsody Single-Cell Analysis Reagent Kits. These kits are used for the manufacture of human cells and tissue-based products utilized in phase I/II clinical protocols for transplantation, adoptive immunotherapy, and gene therapy conducted in the Clinical Center at the NIH. The procurement includes a standing order for multi-type sequencing kits and reagents with a short shelf life. The contractor will be responsible for shipping the sufficient reagents and kits following the scheduled delivery dates. The shelf life of the sequencing reagents should be at least 3 months, and the shelf life of library generation kits should be at least 6 months. The contractor is also required to provide technical support for all kits and reagents at no additional cost. The period of performance for this procurement is from 5/1/2024 to 8/30/2024. The delivery schedule is overnight delivery Monday through Thursday to the Center for Cellular Engineering (CCE) at NIH/CC in Bethesda, MD. The vendor will be responsible for ensuring the safe transport of cryopreserved patient cells and maintaining the temperature and other parameters during the shipment of reagents and kits. The contractor will be paid per product delivered and is required to provide hard copies of proofs of each product delivered. Interested parties can submit their capabilities to the Office of Purchasing and Contracts by May 1st, 9:00 AM EST. Please note that this is not a request for proposal.
    MAINTENANCE CONTRACT FOR THERMO ELECTRON CORP QEHF-LC EQUIPMENT
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking quotes for a maintenance contract for Thermo Electron Corp Q-EHF-LC equipment, crucial for the Laboratory of Immune System Biology's research efforts. The procurement involves maintenance services for a high-demand mass spectrometer and associated laboratory equipment, ensuring accurate data collection and system functionality. This maintenance is vital to prevent delays in critical research, as the equipment is used for analyzing irreplaceable samples. Interested vendors must contact Mildred Moss at mildred.moss@nih.gov or Tonia Alexander at talexander@niaid.nih.gov for further details, with the solicitation number RFQ-NIAID-25-2243700 issued under Simplified Acquisition Procedures.
    CYTEK AURORA 5 LASER WITH LOADER - UV/V/B/YG/R - PREMIUM SERVICE AGREEMENT
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking quotes for a premium service agreement for a Cytek Aurora 5 laser with loader, which is essential for advanced laboratory applications. The procurement includes comprehensive maintenance services, such as preventive inspections, technical support, and on-site assistance, ensuring optimal functionality of the equipment throughout the contract period from December 1, 2024, to November 20, 2025. This acquisition is critical for supporting the NIH's research initiatives in allergy and infectious diseases, emphasizing the importance of reliable laboratory equipment and services. Interested vendors must submit their quotations via the NIAID electronic Simplified Acquisition Submission System (eSASS) by November 13, 2024, at 12:00 am EST, and can contact Maliaka Pinkney or Jesse D Weidow for further inquiries.
    Reagent Generation for Bioanalytical Method Development on Biologics
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified sources for a potential contract focused on reagent generation for bioanalytical method development related to biologics. The primary objective is to obtain information on the availability and capability of companies to generate and deliver reagents, including anti-drug antibodies, that support the quantification of novel biologic drugs in various biological matrices. This initiative is crucial for advancing drug development processes and improving success rates in preclinical stages, with the Therapeutic Development Branch (TDB) at NIH playing a pivotal role in moving therapeutic candidates through the drug development pipeline. Interested parties must submit their capability statements by November 8, 2024, to Nick Niefeld at nick.niefeld@nih.gov, referencing sources sought notice number 75N95025R00007.
    BIOFIRE Defense, LLC Test Kits and Reagents
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a fixed-price contract to BioFire Defense, LLC for the provision of BIOFIRE® Reagent Kits and associated test kits. The procurement aims to secure proprietary test kits and reagents essential for the NIH Clinical Center's Department of Laboratory Medicine, which supports patient care and research by detecting pathogens in various patient specimens, including blood and respiratory samples. The BioFire test kits are critical for rapid diagnostics, allowing clinicians to initiate timely treatment for infections, and BioFire Defense, LLC is the sole source for these products due to compatibility requirements with government-owned analyzers. Interested parties capable of providing similar products may submit capability statements by November 17, 2024, at 12:00 PM EST to Sheri Eiri at sheri.eiri@nih.gov.
    NOI Cytiva Sepax C-Pro Cell Processing Systems Software Upgrade
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to award a firm fixed price contract for a software upgrade on two Cytiva Sepax C-Pro Cell Processing Systems. The objective of this procurement is to enhance the functionality of these systems, which are critical for the Department of Transfusion Medicine, thereby reducing the need for alternative devices and associated maintenance costs. This sole source acquisition is justified as Cytiva-Global Life Sciences Solutions USA LLC is the original equipment manufacturer and the only qualified provider for the proprietary software required for the upgrade. Interested parties must submit capability statements by November 14, 2024, at 12:00 PM EST to Sheri Eiri at sheri.eiri@nih.gov for consideration.